Tag:
Delcath
Latest Headlines
Latest Headlines
Delcath shares slump after chemo system fails to deliver in PhII cohort
Shares of Delcath Systems ( $DCTH ) slumped 11% this morning after the drug delivery company said its chemosaturation system did not prove effective in a small, mid-stage trial involving a cohort of
Delcath in a tailspin after FDA punts back NDA
The FDA handed back Delcath Systems' ( $DCTH ) NDA for its targeted chemosaturation system along with a refuse-to-file letter outlining the agency's demands for additional information. And investors
Delcath shares shoot up on promising trial results
Shares of Delcath Systems shot up 24 percent yesterday evening after the company reported that its anti-cancer technology hit the primary goal of a late-stage trial. The study compared Delcath's PHP
